NCT02281786View on ClinicalTrials.gov

A Study of RO6926496 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy Volunteer
Interventions
DRUG

Placebo

Matching placebo to RO6926496

DRUG

RO6926496

single, ascending dose, intravenous administration

Trial Locations (1)

LS2 9LH

Leeds

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02281786 - A Study of RO6926496 in Healthy Volunteers | Biotech Hunter | Biotech Hunter